Patient-specific forecasting of postradiotherapy prostate-specific antigen kinetics enables early prediction of biochemical relapse.

Otherwise, if EBRT does not eradicate the tumor completely, the surviving cancerous cells will ultimately drive tumor growth after EBRT conclusion and, hence, produce an increasing trend in PSA.

also in 63,971 other papers